ArriVent BioPharma

ArriVent Reports Promising Results for Firmonertinib in Lung Cancer Patients With Rare EGFR Mutations

NEWTOWN SQUARE, PA – ArriVent BioPharma, Inc. (Nasdaq: AVBP) presented final proof-of-concept results from its global Phase 1b FURTHER trial of firmonertinib, an oral targeted therapy for patients with non-small …

ArriVent Reports Promising Results for Firmonertinib in Lung Cancer Patients With Rare EGFR Mutations Read More




Pennsylvania Man Indicted in Chilling Federal Child Exploitation Case

PHILADELPHIA, PA — United States Attorney David Metcalf announced that Mark Wills, also known by several aliases including “Lorenzo Guerra,” “Alex Harrison,” “kevthompson2009,” “18kevinmcbride,” and “leonardobrickma,” has been indicted on …

Pennsylvania Man Indicted in Chilling Federal Child Exploitation Case Read More